PureTech Health plc

PureTech Health plc

PTCHF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$405.77M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
PureTech Health plcPureTech Health plc159.1-13%--
$0.86

Current Fair Value

48.1% downside

Overvalued by 48.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$405.77 Million
Enterprise Value$301.86 Million
Earnings per Share$-0.47
Beta0.79
Outstanding Shares242,759,446

Return

Return on Equity13.50%ROE
Return on Assets8.18%
Return on Invested Capital-8.54%

Valuation & Multiples

P/E Ratio159.07P/E Ratio
PEG-63.99PEG
Price to Sales-Price to Sales
Price to Book Ratio1.66Price to Book Ratio
Enterprise Value to Revenue24.78
Enterprise Value to EBIT-6.08
Enterprise Value to Net Income5
Total Debt to Enterprise0.06
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 22, 2026
EPS
$0.27
Est. -$0.12
Revenue
$3.56 M
Est. $24.80 M

Next Earnings Call

Expected Date
April 29, 2027
EPS Estimate
-$0.11
Consensus analyst estimate
Revenue Estimate
$5.00 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About PureTech Health Plc

66 employees
CEO: Daphne Zohar

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurologic...